Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Annales De Gastroenterologie Et D'Hepatologie|November 1, 1996
[Low prevalence of ant-hepatitis c virus antibodies in hepatocellular carcinoma in Senegal]M M Ka, P Herve, B Leguenno, et al.
Leukemia|January 1, 1992
Autologous bone marrow transplantation vs intensive chemotherapy in first complete remission: interim results of GOELAM study in AMLJ L Harousseau, B Pignon, P Dufour, et al.
British Journal of Haematology|August 1, 1985
Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin's lymphomaT Philip, P Biron, D Maraninchi, et al.
British Journal of Cancer|June 1, 1986
High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's diseaseT Philip, J Dumont, F Teillet, et al.
Bone Marrow Transplantation|April 1, 1993
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMTC Belanger, H Esperou-Bourdeau, P Bordigoni, et al.
Annales De La Societe Belge De Medecine Tropicale|September 1, 1995
[Malaria and rice growing in the Senegal River delta (Senegal)]O Faye, D Fontenille, O Gaye, et al.
Bone Marrow Transplantation|April 1, 1990
High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: a retrospective analysis of 35 patients treated in FranceP Viens, D Maraninchi, M Legros, et al.
Blood|April 15, 1990
Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purgingN C Gorin, P Aegerter, B Auvert, et al.
Leukemia|October 1, 1991
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT)N C Gorin, M Labopin, G Meloni, et al.
Transplantation|February 27, 1996
Evidence that a transient enhancement of endogenous hematopoiesis contributes significantly to the favorable outcome following interleukin 1 pretreatment and allogeneic bone marrow transplantationV Herve, M Mabed, V Laithier, et al.
Pageof 17